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ScienceDirectConcepts of epilepsy, based on a simple change in neuronal
excitation/inhibition balance, have subsided in face of recent
insights into the large diversity and context-dependence of
signaling mechanisms at the molecular, cellular and neuronal
network level. GABAergic transmission exerts both seizure-
suppressing and seizure-promoting actions. These two roles are
prone to short-term and long-term alterations, evident both
during epileptogenesis and during individual epileptiform events.
The driving force of GABAergic currents is controlled by ion-
regulatory molecules such as the neuronal K-Cl cotransporter
KCC2 and cytosolic carbonic anhydrases. Accumulating
evidence suggests that neuronal ion regulation is highly plastic,
thereby contributing to the multiple roles ascribed to GABAergic
signaling during epileptogenesis and epilepsy.
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Much of the neurobiological research on epilepsies has
focused on the role of GABAergic transmission in various
phases of disease progression. Alterations in GABAergic
signaling, which include changes in the properties of
interneurons and in their quantitative as well as qualita-
tive postsynaptic effects, are intimately involved in the
development and chronic manifestations of epileptiform
activity. In this review, we focus on GABAA receptor
(GABAAR) functions and the ion transporters which
affect the reversal potential of GABAAR-mediated cur-
rents (EGABA). ‘Ionic plasticity’ [1] (Figure 1) refers to
changes in neuronal signaling related to the operation and
functional modulation of plasmalemmal ion transporters
Open access under CC BY license. Current Opinion in Neurobiology 2014, 26:34–41 (Figure 2a) which set EGABA either directly (Cl
 and/or
HCO3
 transporters) or indirectly (the Na-K ATPase).
Epilepsies have turned out to be a spectrum disorder with
a range of etiologies and comorbidities. Concepts of
epilepsy and epileptogenesis seem likely to undergo
revisions [2,3]. Here we will mainly focus on mesial
temporal lobe epilepsy (TLE) which is the most common
type of refractory epilepsy. The primary cause leading to
TLE is typically an insult to the brain (traumatic brain
injury, inflammation, status epilepticus), but in patients
the nature of the initial insult remains often unknown
because of long delays between the insult and appearance
of the recurrent seizures characteristic of TLE [4].
Seizures in the non-epileptic brain
Seizures can take place in disease states other than epi-
lepsy. Refractory status epilepticus (SE), a life-threatening
epileptic crisis characterized by prolonged recurrent sei-
zures which do not respond to diazepines [5], is caused by
factors such as inflammation and stroke, and it is seen in a
minority of patients with established epilepsy. Much of our
knowledge on the mechanisms and consequences of sei-
zures come from in vivo and in vitro work on animals with
no previous history of epilepsy or epileptogenesis. Induc-
tion of experimental SE has been shown to produce fast
and robust changes in neuronal plasticity and a fast de-
velopment of pharmacoresistance to conventional antiepi-
leptic drugs which enhance GABAergic transmission. A
straightforward explanation (see [6,7]) is that recurrent
seizures lead to a progressive internalization of postsyn-
aptic GABAARs and to a consequent erosion of inhibition.
Work on brain slices has shown that the efficacy of feedfor-
ward inhibition declines rapidly after recurrent seizure-like
activity, leading to a loss of the powerful inhibitory sur-
round that is initially associated with these paroxysmal
events [8,9,10]. Seizures evoked in healthy adult brain
tissue induce a fast decrease in the expression of KCC2
[11–13], the main neuronal Cl extruder. This molecule
underlies classical, ‘Eccles-type’ hyperpolarizing inhibi-
tory postsynaptic potentials (IPSPs) in central neurons
[14]. GABAergic inhibition also has a shunting effect on
electrical signals in the postsynaptic membrane (Box 1).
The downregulation of GABAARs and KCC2 in response
to trauma and/or intense seizure activity (Figure 2b) leads
to a long-lasting decrease in the efficacy of both shunting
and voltage inhibition, respectively.
The extrusion capacity of KCC2 can saturate even in the
absence of functional downregulation [15] of the trans-
porter. Therefore, the loss of voltage inhibition in response towww.sciencedirect.com
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Figure 1
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Ionic plasticity of GABAA receptor signaling
Neuronal/synaptic plasticity has traditionally been associated
with modulation of the functional expression and properties of 
channels (ionic conductances, Gi).
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Ionic plasticity of GABAA receptor signaling refers to         
modulation of neuronal functions via changes in the driving force 
DFGABA = Vm − EGABA via short- and long-term mechanisms:
(1) Activity-evoked, channel-mediated changes in Cl- and 
 HCO3- gradients which control EGABA
(2) Changes in the functionality (trafficking, kinetics, and 
 synthesis/degradation) of ion-regulatory molecules such as 
 cation-chloride cotransporters (KCC2, NKCC1), the Na-K 
 ATPase and carbonic anhydrases
An important property of GABAA  receptor-mediated signaling is 
the uniquely high sensitivity of EGABA and, consequently DF GABA to 
activity-induced Cl- fluxes and to changes in the efficacy of KCC2- 
mediated Cl- extrusion. The diagram below depicts the time 
domains of neuronal Cl--loading mechanisms following seizure  
activity.
Ionic plasticity of GABAA receptor signaling.seizure activity is likely to be much faster than the loss of
shunting. This is because the intense activation of inter-
neurons will lead to a massive Cl influx which is aided by
the depolarizing currents mediated by HCO3
 across
GABAARs and by coactivation of glutamatergic ionotropic
receptors [16], as shown by continuous monitoring of
EGABA [17]. In fact, the depolarization mediated by the
HCO3
 current can drive a Cl influx that is large enough
to induce a qualitative change in GABAAR-mediated
signaling from inhibitory to excitatory [17,18]. During
intense GABAAR activation, the driving force of the inward
HCO3
 current is much more stable than that of the
outward Cl current because the intracellular HCO3
 is
effectively replenished by neuronal cytosolic carbonic
anhydrase [19,20]. Indeed, under experimental conditions
with enhanced synaptic release of GABA, pharmacologi-
cally isolated GABAAR-mediated transmission alone is
able to produce spontaneous paroxysmal activity in the
brain slice [21]. The effect of the HCO3
-dependent anion
shift is augmented by KCC2-mediated net accumulation of
K+ in the interstitial space [18], leading to further, non-
synaptic depolarization and excitation of neurons. Thiswww.sciencedirect.com probably includes (the at its time enigmatic observation of)
GABA-driven antidromic spiking [22]. The membrane
potential of glial cells is highly sensitive to extracellular
K+, and the above positive feedback loop may act in
synergy with glutamate release [23] from depolarized glia
[17] to sustain a seizure. GABAARs and the Na-K-2Cl
cotransporter NKCC1 (but not KCC2) are expressed in
presynaptic terminals [14], and thus the antidromic spiking
might also involve a direct presynaptic GABAAR depolar-
ization following an activity-dependent anion shift within
the terminal. The role of extracellular K+ is a classical focus
in epilepsy research [24], and the time is ripe to readdress
this topic with the novel insight pointing to GABAergic K+
transients as a major pro-convulsant mechanism [25,26].
Seizures in the epileptic brain
It is likely that seizure mechanisms in chronically epileptic
tissue differ dramatically from those evoked in brain tissue
in healthy experimental animals or observed in patients
with no previous history of epilepsy. Even if no cognitive
defects are detectable during seizure-free periods of time,
the cortex of chronically epileptic patients generatesCurrent Opinion in Neurobiology 2014, 26:34–41
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Neuronal ion regulation sets the driving force for GABAA receptor-mediated currents. (a) The cation chloride cotransporters govern neuronal Cl

regulation. In mature neurons the K-Cl cotransporter isoform 2, KCC2, mediates Cl extrusion driven by the K+ gradient while the Na-K-2Cl
cotransporter isoform 1, NKCC1, mediates Na+ driven Cl uptake. In addition to this, the Na+-independent and Na+-dependent Cl-HCO3 exchangers
AE3 and NDCBE, respectively, may modulate intracellular Cl levels. The main function of these HCO3
 transporters, together with the ubiquitous Na-
H exchanger (not depicted), is to keep the intracellular pH level significantly more alkaline than what is predicted on the basis of passive distribution of
H+ and HCO3
 ions. Hence, the equilibrium potential for HCO3
 is much more positive than the resting membrane potential and HCO3
 invariably
mediates a depolarizing current across GABAARs. Intracellular HCO3
 concentration is rapidly replenished even during prolonged GABAAR activation
via the activity of carbonic anhydrase isoforms 2 and 7 (CA2 and CA7) which catalyze the formation of HCO3
 from CO2 [20
]. (b) The cation-chloride
cotransporters shown in panel (a) are fueled by the Na+ and K+ gradients generated by the Na-K ATPase. The conventional, GABAAR-mediated
hyperpolarizing IPSPs seen in mature neurons depend on the functional expression of KCC2 (left) that maintains a low intracellular Cl level that favors
conductive Cl influx. Seizure-induced post-translational changes in CCC functional expression, e.g. via altered membrane expression, commence in
tens of minutes. Prolonged changes at the levels of post-translational modification and transcription convert GABAAR signaling back to its immature,
depolarizing/excitatory mode of action during the course of epileptogenesis (right). The positive shift in EGABA assists in reducing energy consumption
during ‘energy crisis’ by reducing the driving forces of temporally overlapping and mutually counteracting excitatory and inhibitory postsynaptic ion
fluxes (see [16]). For further details, see text.abnormal interictal activities which are seen as brief (tens
of milliseconds) spikes in the EEG. In hippocampal tissue
from TLE patients, the in vitro counterpart of interictal
activity is highly sensitive to bumetanide [27], a drug that
selectively blocks Cl uptake mediated by NKCC1 in
neurons in vitro [26]. In a manner similar to the depolarizing
GABAAR actions and associated NKCC1-dependent net-
work events in the immature rodent hippocampus [14],
interictal activity in vitro shows an obligatory dependence
on excitatory GABAergic and glutamatergic excitatory
synaptic drive [28,29]. In hippocampal tissue resected
from human TLE patients, intracellular recordings have
revealed a subpopulation of pyramidal neurons where
KCC2 levels are low and GABA has an excitatory actionCurrent Opinion in Neurobiology 2014, 26:34–41 [27,28] (see also [13]). Thus, GABAAR signaling appears to
resume its immature, depolarizing/excitatory mode of
action at least in some pyramidal neurons during the course
of epileptogenesis. However, while the changes in cation-
chloride cotransporter (CCC) expression levels (low
KCC2, high NKCC1) in these cells provide an explanation
for the generation of interictal activity, there are no data to
suggest that ictogenesis is based on these mechanisms (for
review see [26]).
Intriguingly, it seems to be more difficult to evoke
seizures in human TLE tissue than in brain tissue from
healthy animals [30]. This is a difficult paradox, since
surgically obtained human TLE tissue typically has awww.sciencedirect.com
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Box 1 Synaptic and extrasynaptic GABAAR signaling
Synaptic GABAAR-mediated inhibition is based on shunting and
hyperpolarization of the postsynaptic membrane. Shunting inhibi-
tion has a duration set by the GABAAR channels’ open time, and the
associated increase in conductance acts to suppress the temporal
and spatial summation of incoming excitatory synaptic signals, as
well as intrinsic pro-excitatory currents generated in the dendritic
tree. Voltage inhibition, which hyperpolarizes the postsynaptic
membrane, is dependent on the inwardly-directed electrochemical
gradient of Cl, maintained by KCC2, and it counteracts excitatory
mechanisms for a longer time period, which is set by the time
constant of the cell membrane. Unlike shunting, voltage inhibition
does not take place in all types of mature CNS neurons because of
cell-type specific lack of KCC2. The postsynaptic GABAARs in the
neocortex and hippocampus consist of a(1-3), b(x) and g2 subunits
[80] whereof the of a1b2g2 is the most common one.
Tonic GABAAR-mediated signaling is based on the activation of
high-affinity extrasynaptic GABAARs (with a subunit combination
consisting of a5bg2, a4bd or a1bd in neocortical and hippocampal
neurons) by ambient GABA. The subunit composition of GABAARs
undergoes marked changes during epileptogenesis with consequent
changes in the abundance of postsynaptic and extrasynaptic
receptors [81], often followed by an increase in tonic inhibition [82].
Tonic GABAergic signaling is highly sensitive to changes in the
efficacy of GABA uptake transporters (GAT1-4) [83], and it produces
a spatially extended shunting effect in the target neurons, with
voltage changes set by DFGABA. Excessive tonic inhibition is known
to promote absence seizures by inducing slow-wave discharges in
thalamo-cortical networks, while enhancing tonic inhibition has an
anticonvulsant action in partial seizures and catamenial epilepsy [84].
Synaptic GABAergic signaling is often called ‘phasic’ (e.g. ‘phasic
inhibition’) to underscore its distinct properties versus tonic signal-
ing. Both phasic and tonic GABAAR-mediated signaling can be
functionally inhibitory or excitatory, depending on the ion-regulatory
mechanisms which set EGABA and DFGABA; on the GABAAR-mediated
conductance; and on the intrinsic electrophysiological properties of
the target neuron.sclerotic CA1 region, and such macroscopic differences in
the properties of the healthy versus chronically diseased
circuitry will compromise evaluation of the effects of
distinct CCCs or changes in their expression. In slices
from human TLE tissue, seizure-like events are not
preceded by interictal but rather by ‘pre-ictal’ events
which are largely based on recurrent glutamatergic sig-
naling [29,31]. These bursts have a wide spatial extent
and a high propagation speed which probably makes them
particularly effective in activating interneurons [30].
While dendritic GABAergic synapses are lost in animal
models of chronic epilepsy [32], a wealth of data suggest
that parvalbumin-positive, perisomatically targeting
interneurons shape the rhythmicity and synchrony which
makes it possible for the seizures to effectively spread
across wide cortical territories [33].
What triggers seizures in TLE? The diversity of recent
explanations shows that this fundamental problem has
still not been satisfactorily solved. We note that the term
‘trigger’ is ambiguous in that it has been used to describe
(i) extrinsic factors that increase the propensity of seizures
(e.g. hyperventilation or fever in children) and (ii) thewww.sciencedirect.com intrinsic neuronal and network mechanisms that act as
immediate causes for seizure generation. Here, we will
consider the latter. There is evidence that local desyn-
chronization of neuronal activity is needed for the
initiation of seizure activity [34]. Thus, a simple working
hypothesis for the generation of TLE-related seizures
and the role of KCC2 therein might be constructed as
follows: In the seizure-triggering ‘kernel’ of diseased
tissue, pre-ictal activity leads to a loss of phasic hyper-
polarizing IPSPs (Box 1), which results (over short times)
from the high Cl load [35,36] and is enhanced and
consolidated largely by post-translational downregulation
of membrane-associated KCC2 [37,38] and later (cf.
[37]) by block of KCC2 transcription (Figure 1). The
lack of hyperpolarizing IPSPs will lead, in turn, to the
local desynchronization and promotion of seizures [34].
This idea is consistent with and supported by the actions
of hyperpolarizing inhibition on spike probability and
timing in healthy tissue [39].
TrkB and calpain as coordinating factors in
epileptogenesis and epilepsy
BDNF-TrkB signaling has been put forward as a coordi-
nating factor in epileptogenesis [40–42]. Indeed, the
parallel loss of postsynaptic GABAARs and KCC2 after
recurrent seizures may imply a shared mechanism, which
most likely consists of signaling cascades down-stream of
the tropomyosin-related kinase B (TrkB) receptor [40],
the main target of brain-derived neurotrophic factor
(BDNF). Seizures enhance BDNF secretion and the
activation of TrkB [41] but, notably, BDNF itself is
not always responsible for seizure-induced TrkB acti-
vation (cf. [43]). Conditional knockout of TrkB [44],
transient inhibition of TrkB [45] or uncoupling of TrkB
from the PLCg1 cascade [46] are all reported to suppress
epileptogenesis. Enhanced TrkB activation in mature
neurons rapidly decreases surface expression of
GABAARs [47,48] and downregulates KCC2 [12,49].
There exist close parallels between the role of BDNF-
TrkB signaling in epilepsy and in chronic pain [50]. In
both cases, inflammation may induce BDNF secretion
from activated microglia, and cause a downregulation of
KCC2 in adjacent neurons [50]. Notably, inflammation is
also a major cause of SE and epileptogenesis [51].
Fast, seizure-induced downregulation of KCC2 activity
(over tens of minutes to hours), depends on post-
transcriptional mechanisms [15,37], including protein
phosphatase 1-mediated dephosphorylation of KCC2 at
serine 940 [38,52] and cleavage by the protease calpain
[37,52], which is activated by Ca2+ and/or BDNF (for
review, see [53]). A decrease in KCC2 mRNA occurs within
hours of a seizure [12] and may contribute to consolidate
KCC2 downregulation (Figure 1), but is not needed for
chronic suppression of KCC2 protein expression or Cl
extrusion [54]. Indeed, the increased level of calpain
expression observed in TLE tissue [55,56] could accountCurrent Opinion in Neurobiology 2014, 26:34–41
38 Inhibition: synapses, neurons and circuitsfor the chronic suppression of hippocampal KCC2 expres-
sion observed in patients with chronic epilepsy (see above).
Interestingly, up-regulation of the gene encoding for the
endogenous calpain inhibitor calpastatin is observed
during the acute and latent phase of limbic epileptogen-
esis, whereas this enhancement appears to be lost in the
chronic phase, characterized with spontaneous recurrent
seizures [57]. Notably, calpain cleaves not only KCC2
[37,52,54] but also other proteins involved in GABAergic
transmission, including GAD65 [58], VGAT/VIIAT [59],
GAT1 [60] and gephyrin [61]. Thus, mounting evidence
suggests that activation of calpain is another coordinating
factor in epileptogenesis with important effects on GABA-
ergic signaling (see also [62]).
Developmental stage and seizure
mechanisms
Neuronal signaling mechanisms are radically different in
developing and mature brain. One of the best examples is
GABAAR-mediated signaling, which undergoes a well-
known ‘developmental shift’ from depolarizing/excit-
atory to hyperpolarizing (for review, see [14,63]). Initially
neuronal Cl accumulation by NKCC1 is dominant, and
KCC2 is expressed later during neuronal maturation [14].
The maturation of KCC2-dependent hyperpolarizing
inhibition is accompanied by the expression of neuronal
carbonic anhydrase isoform 7 (CA7), at around postnatal
day (P) 12 in rodent hippocampus [64], followed by
neuronal expression of the ubiquitous CA isoform 2
(CA2) at P20 [20]. The simultaneous presence of KCC2
and CA activity is crucial both for the generation of
GABA-dependent neuronal Cl loads in response to
interneuronal activity, and for paroxysmal extracellular
K+ transients [18]. The key role of NKCC1 in immature,
depolarizing GABAergic transmission and GABA-driven
network events has led to a number of studies in neonatal
rodents on the possible therapeutic use of the NKCC1
blocker, bumetanide. This work has been largely disap-
pointing, as described elsewhere [26]. Cortical develop-
ment is much more advanced in the human newborn than
in the rodent [65]. Unlike in neonate rodents, CA7 and
KCC2 are both expressed at high levels in hippocampus
and neocortex of full term human babies [15,20,66,67].
This major species difference has numerous implications
for translational work on the mechanisms of GABAergic
signaling and seizures.
Adaptive mechanisms
From an evolutionary point of view, it is easy to under-
stand why neurons and neuronal networks are endowed
with adaptive response patterns which promote their
survival under various insults [68]. Adaptive mechanisms
can be detected, for instance, in the slowing of disease
progression induced by application of proconvulsant
drugs such as atipamezole and rimonabant soon after
an insult [69,70]. Moreover, whether disease stage-
related expression patterns of the endogenous calpainCurrent Opinion in Neurobiology 2014, 26:34–41 inhibitor calpastatin [57] (see above) are causally
involved here, is an interesting question for future work.
Clearly, empirical information is required to judge
whether a disease-related change at the molecular, cel-
lular or network level is a ‘dysfunction’ (maladaptive,
pro-epileptogenic) or an adaptive (anti-epileptogenic)
process.
After trauma, neurons undergo processes of de-differen-
tiation, seen as a shift in gene expression patterns to those
of earlier developmental stages [1,71]. The adaptive
value of such processes may be best explained from
the factors involved in neuronal survival after trauma:
(i) downregulation of energy metabolism under con-
ditions of an ‘energy crisis’ (see [72]); as well as the
presence of (ii) sufficient connectivity and (iii) trophic
factor signaling, which promote neuronal survival. With
regard to (i), the mammalian brain works close to theor-
etical limits on energy consumption, with most of it used
to maintain the ionic driving forces which are needed for
electrical signaling [16,73]. Changes in the functions and
expression patterns of ion transporters and channels may
thus have evolved as adaptive mechanisms to protect
neurons during states of energy crisis. This idea fits well
with the fast downregulation of both ion transporters and
channels (e.g. GABAARs and KCC2) in response to
seizures (see above and Figure 2b). Furthermore, the
Na-K ATPase, the major ion-regulatory and energy-con-
suming molecule of the brain, is functionally downregu-
lated after trauma or seizure [26,74]. The Na-K ATPase
and KCC2 are functionally tightly linked, and there is
evidence that the two molecules form a structural ion-
transport metabolon [75,76]. We note also that shutting
down Cl permeable GABAARs will reduce the energy-
metabolic load imposed by cation-based glutamatergic
signaling [16].
Conclusions
Changes in excitation–inhibition (E/I) balance are often
used to explain epileptogenesis and seizure generation
but, as should be obvious from the work reviewed above,
the explanatory value of the E/I balance in the context of
epilepsy is limited. Moreover, the postulated cause (E/I
imbalance) is deduced from the outcome (seizures),
which is an obvious circular argument. A gross change
in the E/I imbalance is not, either, consistent with the fact
that seizures in chronic epilepsy can occur infrequently
and unpredictably, with intervening periods of intact
cognitive and mnemonic cortico-hippocampal functions.
The studies reviewed presently demonstrate that
GABAAR signaling has multiple, context-specific and
age-specific actions which can prevent or promote epi-
leptogenesis and seizure generation. A context-specificity
and age-specificity is true also for intracellular signaling
cascades such as those down-stream of TrkB receptors
[76–78], which exert a strong influence on neuronal
plasticity. This context-dependent diversity in cellularwww.sciencedirect.com
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basic research on the etiology and mechanisms of epi-
leptiform syndromes, but also for the design of novel,
genuinely antiepileptic drugs [79] which, instead of hav-
ing solely symptomatic anticonvulsant actions, would halt
and even reverse the progression of epilepsy.
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